Top Markets
#1 Resolv wstUSR Resolv wstUSR +114.61%
#2 Luxxcoin Luxxcoin +45.15%
#3 ResearchCoin ResearchCoin +21.62%
#4 Reactive Network Reactive Network +21.45%
#5 Layer3 Layer3 +19.67%
#6 Orderly Network Orderly Network +16.55%
#7 Aria.AI Aria.AI +12.61%
#8 Bitgert Bitgert +11.76%
#9 Lisk Bridged wstETH (Lisk) Lisk Bridged wstETH (Lisk) +9.32%
#10 KAITO KAITO +9.04%
Coin of the day
Resolv wstUSR Resolv wstUSR
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
CSL Limited CSL Limited

CSL Limited

CSL
Classificação em ações #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Preço da ação
$99.32
Valor de mercado
$48.20B
Variação (1 dia)
0.98%
Variação (1 ano)
-32.14%
País
AU
Negociar CSL Limited (CSL)

Categoria

Healthcare
EPS de CSL Limited (CSL)
EPS em December 2025 TTM: $2.98
De acordo com os últimos relatórios financeiros e o preço das ações da CSL Limited, o EPS atual da empresa (TTM) é $2.98. No final de 2024, a empresa teve um EPS de $5.47, um aumento em relação a ao EPS de 2023, que foi de $4.55.
Histórico de EPS da CSL Limited de 2000 até 2026
EPS no final de cada ano
Ano EPS Alterar
2026 (TTM) $2.98 -51.94%
2025 $6.20 13.35%
2024 $5.47 20.22%
2023 $4.55 -31.37%
2022 $6.63 26.05%
2021 $5.26 13.61%
2020 $4.63 9.20%
2019 $4.24 50.89%
2018 $2.81 -4.42%
2017 $2.94 9.29%
2016 $2.69 -7.88%
2015 $2.92 8.15%
2014 $2.70 21.09%
2013 $2.23 12.45%
2012 $1.98 -0.58%
2011 $1.99 49.05%
2010 $1.34 6.70%
2009 $1.25 7.16%
2008 $1.17 64.09%
2007 $0.71 500.34%
2006 $0.12 -78.01%
2005 $0.54 168.22%
2004 $0.20 202.40%
2003 $0.07 -21.18%
2002 $0.08 -5.06%
2001 $0.09 83.13%
2000 $0.05 0.00%
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $3.62 21.55%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $15.47 419.13%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $43.12 1,346.98%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $9.62 222.85%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $38.32 1,185.91%
NL